Our study demonstrated that inhibiting TRPA1 dampened the shift towards M2 macrophage polarization in a mouse model of pulmonary fibrosis, primarily by blocking the TGF-β1-Smad2 pathway's phosphorylation process. Here, SMAD2 is linked to pulmonary fibrosis.